MYH9 and neoplasm: Furthermore, MYH9 expression and other clinicopathlogical variables including the histological type, p-TNM stage, adjuvant chemotherapy, tumor differentiation, vascular invasion, lymphatic invasion, and pleural invasion were entered into multivariable analysis using the Cox proportional hazards regression model.